Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-alcoholic fatty liver disease.

Ian Homer Y Cua1, Jacob George

  • 1Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.

Hospital Medicine (London, England : 1998)
|March 3, 2005
PubMed
Summary

This review covers non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), detailing diagnostic criteria, disease progression, underlying mechanisms, and patient management strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of coronavirus disease 2019 on the digestive system and its nutritional implications.

Current opinion in clinical nutrition and metabolic care·2021
Same author

Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Hepatology international·2021
Same author

Response to "High-Fat Diet, Hypertriglyceridemia, Hyperlipidemic Acute Pancreatitis: Don't Forget Novel Coronavirus-Induced Acute Pancreatitis".

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2021
Same author

Association of metabolic-associated fatty liver disease and risk of severe coronavirus disease 2019 illness.

JGH open : an open access journal of gastroenterology and hepatology·2020
Same author

Different barriers to nutritional therapy among critically-ill patients with COVID-19.

Clinical nutrition (Edinburgh, Scotland)·2020
Same author

Gastrointestinal Manifestations of COVID-19: Impact on Nutrition Practices.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2020

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions.
  • Non-alcoholic steatohepatitis (NASH) represents a more advanced, inflammatory form of NAFLD.
  • Accurate diagnosis and understanding of NAFLD/NASH are crucial for patient outcomes.

Purpose of the Study:

  • To review the nomenclature and diagnostic basis of NAFLD and NASH.
  • To elucidate the natural history and pathophysiology of these liver conditions.
  • To outline an approach to the clinical management of patients with NAFLD/NASH.

Main Methods:

  • Literature review of nomenclature and diagnostic criteria.
  • Synthesis of data on natural history and pathophysiology.
  • Discussion of current clinical management strategies.

Main Results:

  • Established nomenclature and diagnostic foundations for NAFLD/NASH.
  • Detailed understanding of disease progression and underlying mechanisms.
  • Provided a framework for clinical management.

Conclusions:

  • NAFLD and NASH require precise diagnostic approaches.
  • Understanding pathophysiology aids in predicting disease trajectory.
  • Effective clinical management is essential for improving patient prognosis.

Related Experiment Videos